Latest news
Solid Biosciences (SLDB) Eyes Key Clinical Milestones Amid High Valuation on Price-to-Sales Basis - GuruFocusGuruFocus · Fri, 07 Aug 2026 00:22:30 GMTSolid Biosciences files prospectus for up to $200 million at-the-market stock offering - BitgetBitget · Thu, 06 Aug 2026 22:38:52 GMTSolid Biosciences files prospectus supplement for up to $200 million stock offering - Investing.comInvesting.com · Thu, 06 Aug 2026 21:30:00 GMTSolid Biosciences (NASDAQ: SLDB) sets $200M stock sale capacity - Stock TitanStock Titan · Thu, 06 Aug 2026 21:16:32 GMTSolid Biosciences Inc. Q2 2026: Revenue $0 Net loss $(54.8M), EPS $(0.38) — 10-Q Summary - TradingViewTradingView · Thu, 06 Aug 2026 20:11:01 GMTSolid Biosciences Reports Second Quarter 2026 Financial Results and Provides Business Updates - GlobeNewswireGlobeNewswire · Thu, 06 Aug 2026 20:08:47 GMTFMR LLC and Abigail Johnson (SLDB) disclose 7% beneficial stake in Solid Biosciences - Stock TitanStock Titan · Thu, 06 Aug 2026 14:42:10 GMTBlackRock, Inc. Expands Solid Biosciences (SLDB) Stake with Stra - GuruFocusGuruFocus · Thu, 06 Aug 2026 02:44:29 GMT